Evidence map›Paper›PMID 28356290›Full record

ArticleAmerican journal of physiology. Renal physiology2017

Novel contrast mixture improves bladder wall contrast for visualizing bladder injury.

Pradeep Tyagi, Joseph J Janicki, T Kevin Hitchens, Lesley M Foley, Mahendra Kashyap, Naoki Yoshimura, Jonathan Kaufman

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in American journal of physiology. Renal physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Recent Developments in Imaging in BPS/IC.Current bladder dysfunction reports · 2019
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Pradeep TyagiDepartment of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania; tyagip@upmc.edu.
Joseph J JanickiLipella Pharmaceuticals, Pittsburgh, Pennsylvania.
T Kevin HitchensAnimal Imaging Center, University of Pittsburgh, Pittsburgh, Pennsylvania.
Lesley M FoleyAnimal Imaging Center, University of Pittsburgh, Pittsburgh, Pennsylvania.
Mahendra KashyapDepartment of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Naoki YoshimuraDepartment of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Jonathan KaufmanLipella Pharmaceuticals, Pittsburgh, Pennsylvania.
University of Pittsburgh · USImaging Center · USLipella Pharmaceuticals (United States) · US

Funding

Measuring Bladder Permeability with MRI using a Novel Contrast Agent FormulationR41DK108397 · NIDDK · LIPELLA PHARMACEUTICALS, INC. · PI KAUFMAN, JONATHAN H · 2015 to 2015
$225k
NIDDK NIH HHS R41 DK108397
6 · The paper itself

Abstract

Here, we tested whether combined contrast-enhanced magnetic resonance imaging (CCE-MRI), using a mixture of gadolinium- and iron oxide-based contrast agents, can segment the bladder wall from the bladder lumen. CCE-MRI relies on the differences in particle size and contrast mechanisms of two agents for improved image contrast. Under isoflurane anesthesia, T1-weighted imaging of adult female Sprague-Dawley rat bladder was performed using standard turbospin echo sequences at 7 Tesla, before and after transurethral instillation of 0.3 ml of single-contrast MRI or CCE-MRI composed of 0.4-64 mM of gadolinium chelate (Gd-DTPA/Gadavist) and 5 mM ferumoxytol. Bladder wall contrast was assessed in the control group exposed to saline and in the bladder injury group exposed to 0.5 ml of protamine sulfate (10 mg/ml) for 30 min. CCE-MRI following instillation of 0.4-4 mM Gd-DTPA and 5 mM ferumoxytol mixture achieved segmentation between the bladder lumen and bladder wall. Hyperintensity in the bladder wall combined with hypointensity in the lumen is consistent with the increased diffusion of the dissolved Gd-DTPA and simultaneous localization of the larger nanoparticles of ferumoxytol in the lumen. The normalized hyperintense signal in the bladder wall increased from 0.46 ± 0.07 in control group to 0.73 ± 0.14 in the protamine sulfate-exposed group (

Indexed as

Administration, IntravesicalAnimalsContrast MediaDisease Models, AnimalFemaleFerrosoferric OxideMagnetic Resonance ImagingNanoparticlesOrganometallic CompoundsParticle SizePredictive Value of TestsProtaminesRats, Sprague-DawleyReproducibility of ResultsTime FactorsUrinary BladderContrast MediaFerrosoferric OxidegadobutrolOrganometallic CompoundsProtaminescombined contrast-enhanced magnetic resonance imagingferumoxytolgadoliniumprotamineT1

Identifiers

PMID28356290
PMCPMC5582910
OpenAlexW2603012493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.